Literature DB >> 8899174

High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center.

R J Motzer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899174

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.

Authors:  J Vuky; J McCaffrey; M Ginsberg; T Mariani; D F Bajorin; G J Bosl; R J Motzer
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

2.  Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.

Authors:  G Varuni Kondagunta; Jennifer Bacik; Lawrence Schwartz; Joel Sheinfeld; Dean Bajorin; Jacqueline Vuky; Stephanie Marion; Madhu Mazumdar; George J Bosl; Robert J Motzer
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.